Allarity Therapeutics Inc — Balance Sheet (NASDAQ:ALLR) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics Dividends

Quarterly Annual

Total assets 49.63 M14.54 M11.86 M22.65 M Total liabilities 30.85 M12.65 M14.61 M10.84 M Total equity 18.15 M113 K2.75 M11.81 M Total liabilities & shareholders' equities 49.63 M14.54 M11.86 M22.65 M Total debt ———— Net debt ————

Nouvelles

Premiers patients traités dans l’essai de stenoparib financé par le VA pour le cancer du poumon

First patients dosed in VA-funded stenoparib trial for lung cancer

Allarity commence un essai de phase 2 de la combinaison stenoparib pour le cancer du poumon

Allarity begins phase 2 trial of stenoparib combination for lung cancer

Stenoparib shows promising survival data in ovarian cancer patients

Are Medical Stocks Lagging Boston Scientific (BSX) This Year?

Crude Oil Down 2%; US Durable Goods Orders Decline In July - Domo (NASDAQ:DOMO), Allarity Therapeutics (NASDAQ:ALLR)

US Stocks Mixed; American Woodmark Posts Downbeat Sales - American Woodmark (NASDAQ:AMWD), Allarity Therapeutics (NASDAQ:ALLR)

Allarity Therapeutics stock soars after FDA Fast Track designation

FDA grants fast track designation for Allarity’s ovarian cancer drug

Stock Market Today: S&P 500, Nasdaq Futures Decline— Palo Alto, XP, Allarity Earnings In Focus - Amcor (NYSE:AMCR), Allarity Therapeutics (NASDAQ:ALLR)

Palo Alto Networks, Fabrinet And 3 Stocks To Watch Heading Into Monday - ATN International (NASDAQ:ATNI), Allarity Therapeutics (NASDAQ:ALLR)